Learn More
Apexbio Technology LLC TC-H 106 937039-45-7 5mg

Supplier: Apexbio Technology LLC A44995
TC-H 106 (CAS 937039-45-7) is a selective inhibitor of class I histone deacetylases (HDACs) targeting HDAC1 HDAC2 HDAC3 and HDAC8 with reported IC50 values of 150 nM 760 nM 370 nM and 5000 nM respectively By inhibiting HDAC activity TC-H 106 interferes with the removal of acetyl groups from histone lysine residues thereby modulating chromatin structure and gene expression In cellular assays TC-H 106 increases histone H3 acetylation in lymphoblastoid cells derived from Friedreich s ataxia (FRDA) patients and enhances frataxin mRNA levels in FRDA mouse models These findings highlight its application in studying epigenetic mechanisms and therapeutic approaches related to HDAC inhibition particularly in neurodegenerative disease models
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.